GVHD Cell Therapy for Kids Gets ODAC Backing

(MedPage Today) -- An FDA advisory panel was mostly convinced that remestemcel-L, an investigational cellular therapy, would be a safe and effective treatment for acute graft-versus-host disease (GVHD) in children with no other approved options...